Injectable Segment to Register Higher CAGR During 2021–2028
According to our new research study on “Non-Invasive Aesthetic Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Procedure and End User,” the market is expected to reach US$ 18,656.54 million by 2028 from US$ 6,504.19 million in 2020; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. The report highlights trends prevailing in the market, and the factors driving and hindering the non-invasive aesthetic treatment market growth. The market growth is primarily attributed to the rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness about cosmetic procedures among consumers, and availability of technologically advanced products. However, clinical risks and complications associated with medical aesthetic procedures are restraining the market growth.
Based on procedure, the non-invasive aesthetic treatment market is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest larger market share in 2020, and it is estimated to register the highest CAGR during the forecast period. Factors such as the increasing number of product approvals and launches, rising awareness regarding the benefits of injectables, and overall growth in number of cosmetic surgeries are bolstering the market for this segment. The market for injectables is further segmented into botulinum toxin, calcium hydroxyapatite, hyaluronic acid, polymer filler, and collagen. Further, the market for skin rejuvenation is subsegmented into chemical peel, laser skin resurfacing, and photo rejuvenation. The others segment includes hair removal, nonsurgical fat reduction, sclerotherapy, and cellulite treatment.
The non-invasive aesthetic treatment market is witnessing substantial decline amid the COVID-19 pandemic. Most healthcare research organizations and hospitals are engaged in introducing new products and solutions for the better management of the disease to prevent further deaths. In addition, governments have issued guidelines for the rescheduling or suspension of all elective surgeries with an aim to focus completely on handling the COVID-19 pandemic. This is hampering the demand for non-invasive aesthetic treatments, thus limiting the market growth.
Galderma SA, Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Cutera Inc., Revance Therapeutics Inc., Cynosure, AbbVie Inc., Candela Medical, and Johnson and Johnson Services, Inc. are among the leading companies operating in the non-invasive aesthetic treatment market.
Non-Invasive Aesthetic Treatment Market Report Forecast to 2028
Download Free SampleNon-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Procedure (Injectables, Skin Rejuvenation, and Others) and End-User (Hospitals, Clinics and Medical Spas, and Others), and Geography
The report segments non-invasive aesthetic treatment market as follows:
- Injectables
- Botulinum Toxin
- Calcium Hydroxyapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
By End User
- Hospitals
- Clinics and Medical Spas
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com